Hip Innovation Study of Reverse Hip Replacement

Hip Innovation Technology (HIT) received FDA Investigational Device Exemption (IDE) approval to initiate a pivotal clinical study to further evaluate the company's Reverse Hip Replacement System (Reverse HRS) for use in primary total hip arthroplasty (THA).

The clinical study objective is to evaluate the safety and effectiveness of the Reverse...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0